4.6 Letter

Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development

Related references

Note: Only part of the references are listed.
Article

Therapeutic Development in Psoriasis

Jeffrey M. Sobell et al.

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2016)

Article Dermatology

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

K. Reich et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2015)

Article Medicine, General & Internal

Sample size slippages in randomised trials: exclusions and the lost and wayward

KF Schulz et al.

LANCET (2002)